Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies

Bibliographic Details
Main Author: Z. Paul Lorenc, MD, FACS
Format: Article
Language:English
Published: Wolters Kluwer 2017-09-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526445.68948.be
id doaj-d155bab70f66419492c74b2b3d85dac3
record_format Article
spelling doaj-d155bab70f66419492c74b2b3d85dac32020-11-25T00:55:14ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742017-09-0159S19319410.1097/01.GOX.0000526445.68948.be201709001-00288Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy StudiesZ. Paul Lorenc, MD, FACS0Lenox Hill hospital, New York, NYhttp://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526445.68948.be
collection DOAJ
language English
format Article
sources DOAJ
author Z. Paul Lorenc, MD, FACS
spellingShingle Z. Paul Lorenc, MD, FACS
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
Plastic and Reconstructive Surgery, Global Open
author_facet Z. Paul Lorenc, MD, FACS
author_sort Z. Paul Lorenc, MD, FACS
title Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
title_short Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
title_full Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
title_fullStr Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
title_full_unstemmed Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
title_sort abstract: dwp-450, purified botulinum toxin type a, for the treatment of moderate-to-severe glabellar lines in adult subjects: results from two randomized, double-blind, placebo-controlled, single dose phase iii safety and efficacy studies
publisher Wolters Kluwer
series Plastic and Reconstructive Surgery, Global Open
issn 2169-7574
publishDate 2017-09-01
url http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526445.68948.be
work_keys_str_mv AT zpaullorencmdfacs abstractdwp450purifiedbotulinumtoxintypeaforthetreatmentofmoderatetosevereglabellarlinesinadultsubjectsresultsfromtworandomizeddoubleblindplacebocontrolledsingledosephaseiiisafetyandefficacystudies
_version_ 1725231194596966400